Replies to post #406160 on Amarin Corp Plc (AMRN)

[couldbebetter]

Swg_tdr, My belief is that Vascepa "could" have a massive market in China "if"
AMRN had the right acquirer who had the resources to capitalize on the need
in that nation. China has a graying population that makes them more vulnerable
to CVD. Even if Vascepa were just a drug for the elite there that would still be a
massive market. If AMRN were owned by a BP that could establish itself as
the leader for an effective Omega-3 CVD medication, and one that could keep
potential competitors at bay, (with or without Eddingpharms involvement...That
would be a gamechanger!